ERBB2 and breast carcinoma: Focusing on HER2-negative breast cancer, the most promising therapeutical strategies are probably HER2 vaccines, as they assume that breast cancer cells express HER2 at a higher level than healthy tissues, even in cases of HER2-low and ultra-low breast cancers by IHC (You et al., 2021).